Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis? - Wikidata - awgldk - TriplyDB

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

http://www.wikidata.org/entity/Q48548046

about

Paradoxical Immune Responses in Non-HIV Cryptococcal Meningitis Neurofilament light chain level is a weak risk factor for the development of MS.The only certain measure of the effectiveness of multiple sclerosis therapy is cerebrospinal neurofilament level—NO

P2860

Q35645083-1E129FB1-BB40-43EB-91DA-F6F561EA4104 Q37265143-1BA8A7ED-65F6-4BE1-BF87-6F4AD44F5B36 Q57601807-A61511B1-9B0B-4F82-B854-44A2CA9562C0

P2860

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

http://www.wikidata.org/entity/Q48548046

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

@en

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

@nl

type

label

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

@en

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

@nl

prefLabel

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

@en

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

@nl

P1433

Q48548046-EF99145C-163A-4CC6-A881-BE3D7057CC34

P1476

Q48548046-BFB5D95E-E829-4C1A-A7EA-DC5B31D63C7A

P2093

Q48548046-8354C309-F16D-4664-9A24-E7C2542062D4

Q48548046-97F7B9E9-C2ED-487D-9077-4C60C6A5F97D

P304

Q48548046-16093F78-F15F-417C-8495-F8C1C081BEE3

P31

Q48548046-14C45562-BACB-426C-A079-5665EFB12A18

Q48548046-f8d3fd40-14f0-4efb-b4fb-2f8624ccb039

P356

Q48548046-47C7CB66-20E5-4422-88E1-9D1467458196

P407

Q48548046-EFC576F2-43F9-4B6D-90C0-AE192B31DA38

P433

Q48548046-08FF1648-EAF7-4C14-9E6E-3157AF314C67

P478

Q48548046-43030739-2620-4EFA-A9C1-AEC2E9A17412

P577

Q48548046-0EE16AC5-9FE8-4FD2-BF2C-431BA9335B6A

P698

Q48548046-1AB8B4AC-56B7-450E-AC52-63006389251B

P921

Q48548046-D2D96E0E-9F49-4D2A-9B14-B0EEED712F99

Q48548046-E30BAAC6-7915-4DEA-B5B1-7124F2038647

P356

WNL.0000000000001506

P1433

P1476

Will CSF biomarkers guide future therapeutic decisions in multiple sclerosis?

@en

P2093

Bibiana Bielekova

http://www.w3.org/2001/XMLSchema#string

Michael P McDermott

http://www.w3.org/2001/XMLSchema#string

P304

1620-1621

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/WNL.0000000000001506

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

84

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25809305

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis